Efficacy and Safety of Vildagliptin Compared to Gliclazide in Drug Naive Patients With Type 2 Diabetes

NCT00102388 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

1092

Enrollment

INDUSTRY

Sponsor class

Conditions

Diabetes Mellitus, Type 2

Interventions

DRUG: vildagliptin
DRUG: Gliclazide

Sponsor

Novartis Pharmaceuticals